Computational Design of Multi-Target Drugs Against Breast Cancer
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/7653_2018_24
Reference95 articles.
1. Tinoco G, Warsch S, Glück S et al (2013) Treating breast cancer in the 21st century: emerging biological therapies. J Cancer 4:117–132. https://doi.org/10.7150/jca.4925
2. Hernández-Blanquisett A, Touya D, Strasser-Weippl K et al (2016) Current and emerging therapies of HER2-positive metastatic breast cancer. Breast 29:170–177. https://doi.org/10.1016/j.breast.2016.07.026
3. Jordan VC, Koerner S (1975) Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor. Eur J Cancer 11:205–206. https://doi.org/10.1016/0014-2964(75)90119-X
4. Black LJ, Sato M, Rowley ER et al (1994) Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63–69. https://doi.org/10.1172/JCI116985
5. Komm BS, Chines AA (2012) Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis 4:21–34. https://doi.org/10.1177/1759720X11422602
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interaction of GHK Tripeptide with Receptors Targeted in Some Cancer Studies: A Theoretical Approach with Molecular Docking;Hittite Journal of Science and Engineering;2023-09-30
2. Molecular docking and dynamic simulation to identify potential phytocompound inhibitors for EGFR and HER2 as anti-breast cancer agents;Journal of Biomolecular Structure and Dynamics;2020-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3